MedTrace Logo

A Study of 5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal Metastasis

NCT00149201 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2009-02-03

No results posted yet for this study

Summary

To develop effective chemotherapy regimen against gastric cancer with peritoneal metastasis

Conditions

Interventions

DRUG

5-FU continuous infusion

DRUG

MTX + 5-FU sequential therapy

Sponsors & Collaborators

  • Ministry of Health, Labour and Welfare, Japan

    collaborator OTHER_GOV

  • Japan Clinical Oncology Group

    lead OTHER

Principal Investigators

  • Kuniaki Shirao, MD,PhD · Gatrointestinal Oncology Division, National Cancer Center Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-11-30
Primary Completion
2008-04-30
Completion
2008-04-30

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00149201 on ClinicalTrials.gov